Adenomas not expressing KRAS4A had significantly increased cell proliferation and significantly decreased apoptotic activity with evidence of activation of MAPK and Akt pathways as compared with heterozygous KO and wild-type KRAS harbouring-induced tumours [75]. This evidence concerns the gene KRAS and neoplasm.